Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

UNICHEM

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE

Comment Full text

DEXCEL LTD

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

WATSON LABS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

WATSON LABS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

WATSON LABS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

NOVARTIS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve IMATINIB MESYLATE

Comment Full text

LANTHEUS MEDCL

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve PERFLUTREN

Comment Full text

BAXTER HLTHCARE CORP

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve SCOPOLAMINE

Comment Full text

IMMUNOGEN INC

  • FDA Approval
  • March 22, 2024, 18:15 UTC
  • 35
  • 0 comments

FDA approve MIRVETUXIMAB SORAVTANSINE-GYNX

Comment Full text

ITALFARMACO SA

  • FDA Approval
  • March 22, 2024, 14:58 UTC
  • 33
  • 0 comments

FDA approve GIVINOSTAT

Comment Full text
  • Previous
  • 520
  • 521
  • 522
  • 523
  • 524
  • Next

Search

News categories

  • Technical Exchange News(11754)
  • Event(4259)
  • SEC News(235108)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143223)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin